Lobeline: Structure-affinity investigation of nicotinic acetylcholinergic receptor binding

Journal of Medicinal Chemistry

Volumn 42, Issue 18, 1999, Pages 3726-3731

  Flammia, Dwight ^a   Dukat, Malgorzata ^a   Damaj, M Imad ^a   Martin, Billy ^a   Glennon, Richard A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; LOBELINE; NICOTINE; NICOTINIC RECEPTOR;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION;

ANALGESICS; ANIMALS; BRAIN; LOBELINE; PIPERIDINES; PROTEIN BINDING; RATS; RATS, INBRED STRAINS; RECEPTORS, NICOTINIC; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033539051     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm990286m     Document Type: Article

References (39)

1. Damaj, M. I.; Fei-Yin, M.; Dukat, M.; Glassco, W.; Glennon, R. A.; Martin, B. R. Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice. J. Pharmacol. Exp. Ther. 1998, 284, 1058-1065.
2. Decker, M. W.; Majchrzak, M. J.; Arneric, S. P. Effects of lobeline, a nicotinic receptor agonist, on learning and memory. Pharmacol. Biochem. Behav. 1993, 45, 571-576.
3. Brioni, J. D.; O'Neill, A.; Kim, D. J. B.; Decker, M. W. Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze. Eur. J. Pharmacol. 1993, 235, 1-8.
4. Brioni, J. D.; Decker, M. W.; Sullivan, J. P.; Arneric, S. P. The pharmacology of (-)nicotine and novel cholinergic channel modulators. Adv. Pharmacol. 1997, 37, 153-214.
5. Abood, L. G.; Salles, K. S.; Maiti, A. Structure-activity studies of carbamate and other esters: Agonists and antagonists to nicotine. Pharmacol. Biochem. Behav. 1988, 30, 403-408.
6. Rasmussen, T.; Swedberg, M. D. Reinforcing effects of nicotinic compounds: intravenous self-administration in drug-naïve mice. Pharmacol. Biochem. Behav. 1998, 60, 567-573.
7. Hamann, S. R.; Martin, W. R. Hyperalgesic and analgesic actions of morphine, U50-488, naltrexone, and (-)lobeline in the rat brainstem. Pharmacol. Biochem. Behav. 1994, 47, 197-201.
8. Damaj, M. I.; Patrick, G. S.; Creasy, K. R.; Martin, B. R. Pharmacology of lobeline, a nicotinic receptor ligand. J. Pharmacol. Exp. Ther. 1997, 282, 410-416.
9. Stolerman, I. P.; Garcha, H. S.; Mirza, N. R. Dissociations between the locomotor stimulant and depressant effects of nicotinic agonists in rats. Psychopharmacology 1995, 117, 430-437.
10. Reavill, C.; Walther, B.; Stolerman, I. P.; Testa, B. Behavioural and pharacokinetic studies on nicotine, cytisine and lobeline. Neuropharmacology 1990, 29, 619-624.
11. Khan, I. M.; Buerkle, H.; Taylor, P.; Yaksh, T. Neuropharmacology 1998, 37, 1515-1525.
12. Benwell, M. E.; Balfour, D. J. The influence of lobeline on nucleus accumbens dopamine and locomotor responses to nicotine in nicotine-pretreated rats. Br. J. Pharmacol. 1998, 125, 1115-1119.
13. Sershen, H.; Balla, A.; Lajtha, A.; Vizi, E. S. Characterization of nicotinic receptors involved in the release of noradrenaline from the hippocampus. Neuroscience 1997, 77, 121-130.
14. 3H]-norepinephrine from fetal rat locus coeruleus in culture. J. Neurochem. 1998, 70, 663-670.
15. 3H]dopamine uptake. J. Pharmacol. Exp. Ther. 1997, 280, 1432-1444.
16. Aizenman, E.; Tang, L. H.; Reynolds, I. J. Effects of nicotinic agonists on the NMDA receptor. Brain Res. 1991, 551, 355-357.
17. Lendvai, B.; Sershen, H.; Lajtha, A.; Santha, E.; Baranyi, M.; Vizi, E. S. Neuropharmacology 1996, 35, 1769-1777.
18. Beers, W. H.; Reich, E. Structure and activity of acetylcholine. Nature 1970, 225, 917-922.
19. Sheridan, R. P.; Nilakantan, R.; Dixon, J. S.; Venkataraghavan, R. The ensemble approach to distance geometry: Application to the nicotinic pharmacophore. J. Med. Chem. 1986, 29, 899-906.
20. Glennon, R. A.; Dukat, M. Nicotinic cholinergic receptor pharmacophores. In Neuronal Nicotinic Receptors: Pharmacology and Therapeutic Opportunites; Arneric, S. P., Brioni, J. D., Eds.; Wiley-Liss: New York, 1999; pp 271-284.
21. Barlow, R. B.; Johnson, O. Relations between structure and nicotine-like activity: X-ray crystal structure analysis of (-)-cytisine and (-)lobeline hydrochloride and a comparison with (-)nicotine and other nicotine-like compounds. Br. J. Pharmacol. 1989, 98, 799-808.
22. Glaser, R.; Hug, P.; Drouin, M.; Michel, A. Solution- and solid-state stereochemistry of (-)-α-lobeline hydrochloride and hydrobromide, a respiratory stimulant drug. J. Chem. Soc., Perkin Trans. 1992, 1071-1079.
23. Terry, A. V.; Williamson, R.; Gattu, M.; Beach, J. W.; McCurdy, C. R.; Sparks, J. A.; Pauly, J. R. Lobeline and structurally simplified analogues exhibit differential agonist activity and sensitivity to antagonist blockade when compared to nicotine. Neuropharmacology 1998, 37, 93-102.
24. Ebnother, A. 48. Uber die Mutarotation des Lobelins. Cis-trans-Isomere in der Reihe der Lobelia-Alkaloide. Helv. Chim. Acta 1958, 41, 386-396.
25. Martin, E. L. The Clemmensen Reduction. In Organic Reactions; Adams, R., Buchman, W. E., Fieser, L. F., Johnson, J. R.; Snyder, J. R., Eds.; Wiley and Sons: New York, 1942; Vol. 1, pp 155-209.
26. Wieland, H.; Schopf, C.; Hermsen, W. Die Lobelia-Alkaloide. Justus Liebigs Ann. Chem. 1925, 444, 40-68.
27. Glennon, R. A.; Dukat, M. Nicotine receptor ligands. Med. Chem. Res. 1996, 6, 465-486.
28. Schopf, C.; Lehman, G. Die Synthese des Tropinons, Pseudopelletierins, Lobelanins und verwandter Alkaloids unter Physiologischen Bendingungen. Justus Liebigs Ann. Chem. 1935, 518, 1-37.
29. Snyder, H. R.; Brewster, J. J. Amine exchange reactions of Mannich bases. J. Am. Chem. Soc. 1948, 70, 4230-4232.
30. Mannich, C.; Heilner, G. Synthese von Ketobasen aus Acetophenon, Formaldehyd und Aminsalz. Chem. Ber. 1922, 55, 356-365.
31. Howton, D. R.; Golding, D. R. V. Reduction products derived from α-phenacylpyridine. J. Org. Chem. 1950, 15, 1-7.
32. Beyerman, H. C.; Eveleens, W.; Muller, Y. M. F. On the synthesis and stereochemistry of sedamine. Recl. Trav. Chim. Pay-Bas 1956, 75, 63-74.
33. Phillips, A. P. Catalytic hydrogenation of some 2- and 4-stilbazole methiodides. J. Am. Chem. Soc. 1950, 72, 1850-1852.
34. Stuhmer, W.; Elbrachter, E. N-Substituierte bis(3,3′-phenyl-propyl)amine. Arch. Pharmacol. 1954, 287, 139-142.
35. Lee, J.; Freudenberg, W. Piperidine derivatives. Part 1. Lobelan and related compounds. J. Org. Chem. 1944, 9, 537-546.
36. 3H]nicotine binding to mouse brain homogenate. J. Pharm. Pharmacol. 1988, 40, 793-797.
37. D'Amour, F. E.; Smith, D. L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 1941, 72, 74-79.
38. Dewey, W. L.; Harris, L. S.; Howes, J. S.; Nuite, J. A. The effect of various neurohormonal modulations on the activity of morphine and the narcotic antagonists in tail-flick and phenylquinone tests. J. Pharmacol. Exp. Ther. 1970, 175, 335-342.
39. Hylden, J. L.; Wilcox, G. L. Intrathecal morphine in mice: A new technique. Eur. J. Pharmacol. 1980, 67, 313-316.